Publications

Improving the Cost-efficiency of Preventive Chemotherapy: Impact of New Diagnostics on Stopping Decisions for Control of Schistosomiasis.

Coffeng, LE; Graham, M; Browning, R; Kura, K; Diggle, PJ; Denwood, M; MEDLEY, GF; Anderson, RM; De Vlas, SJ;

2024

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, (2024).78 Supple 10.1093/cid/ciae020.

Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exercise.

Coussens, AK; Zaidi, SM A; Allwood, BW; Dewan, PK; Gray, G; Kohli, M; Kredo, T; Marais, BJ; Marks, GB; Martinez, L; Ruhwald, M; Scriba, TJ; Seddon, JA; Tisile, P; Warner, DF; Wilkinson, RJ; Esmail, H; HOUBEN, RM G J; International Consensus for Early TB (ICE-TB) grou,;

2024

The Lancet Respiratory Medicine (2024). 10.1016/S2213-2600(24)00028-6.

Chikungunya seroprevalence, force of infection, and prevalence of chronic disability after infection in endemic and epidemic settings: a systematic review, meta-analysis, and modelling study.

KANG, H; AUZENBERGS, M; Clapham, H; Maure, C; Kim, J-H; Salje, H; Taylor, CG; LIM, A; Clark, A; EDMUNDS, WJ; Sahastrabuddhe, S; BRADY, OJ; ABBAS, K;

2024

The Lancet Infectious Diseases, (2024).24 5 10.1016/S1473-3099(23)00810-1.

Reducing the Antigen Prevalence Target Threshold for Stopping and Restarting Mass Drug Administration for Lymphatic Filariasis Elimination: A Model-Based Cost-effectiveness Simulation in Tanzania, India and Haiti.

Antony Oliver, MC; Graham, M; Gass, KM; MEDLEY, GF; Clark, J; Davis, EL; Reimer, LJ; King, JD; Pouwels, KB; Hollingsworth, TD;

2024

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, (2024).78 Supple 10.1093/cid/ciae108.

Effects of sequential vs single pneumococcal vaccination on cardiovascular diseases among older adults: a population-based cohort study.

Tong, X; Gao, L; Wong, IC K; Chan, VK Y; WONG, AY S; Mak, JC W; Yuen, JK Y; JIT, M; Hung, IF N; Yiu, KH; Li, X;

2024

International journal of epidemiology, (2024).53 1 10.1093/ije/dyae005.

Accelerating Progress Towards the 2030 Neglected Tropical Diseases Targets: How Can Quantitative Modeling Support Programmatic Decisions?.

Vasconcelos, A; King, JD; Nunes-Alves, C; Anderson, R; Argaw, D; Basáñez, M-G; Bilal, S; Blok, DJ; Blumberg, S; Borlase, A; Brady, OJ; Browning, R; Chitnis, N; Coffeng, LE; Crowley, EH; Cucunubá, ZM; Cummings, DA T; Davis, CN; Davis, EL; Dixon, M; Dobson, A; Dyson, L; French, M; Fronterre, C; Giorgi, E; ... Fall, IS.

2024

Clinical infectious diseases, (2024).78 Supple 10.1093/cid/ciae082.

Modelling spatiotemporal patterns of visceral leishmaniasis incidence in two endemic states in India using environment, bioclimatic and demographic data, 2013-2022.

Subramanian, S; Maheswari, RU; Prabavathy, G; Khan, MA; Brindha, B; Srividya, A; Kumar, A; Rahi, M; NIGHTINGALE, ES; MEDLEY, GF; CAMERON, MM; Roy, N; Jambulingam, P;

2024

PLoS neglected tropical diseases, (2024).18 2 10.1371/journal.pntd.0011946.

CoMix data (last round in BE, CH, NL and UK).

Jarvis, CI; Coletti, P; Backer, J; Munday, JD; Faes, C; Beutels, P; Althaus, C; Low, N; Wallinga, J; Hens, N; EDMUNDS, J;

2024

, Zenodo (2024).

Modelling the health and economic impacts ofM72/AS01<sub>E</sub> vaccination and BCG-revaccination: Estimates for South Africa.

SUMNER, T; CLARK, RA; Mukandavire, C; Portnoy, A; Weerasuriya, CK; Bakker, R; Scarponi, D; Hatherill, M; Menzies, NA; WHITE, RG;

2024

Vaccine, (2024).42 6 10.1016/j.vaccine.2024.01.072.

MIC distribution analysis identifies differences in AMR between population sub-groups.

Wildfire, J; WATERLOW, NR; Clements, A; FULLER, NM; KNIGHT, GM;

2024

Wellcome Open Research, (2024).9, 10.12688/wellcomeopenres.21269.1.